Markham Drew G reported option exercise involving 119,880 shares of MICROVISION, INC. at $0.00 for $0 on Jun 4, 2026

Option exercise
Form 4 code M. Exercise or conversion of a derivative security exempt under Rule 16b-3.
GC
GC
Filed Jun 5, 2026

Facts from the filing

Form 4 · Non-derivative, table I
Disclosed value
$0Shares × reported price
Shares traded
119,880Common Stock
Price per share
$0.00Reported price. Read footnotes for ranges.
% of reported position traded
UnavailableThis security and ownership context
Holdings after
508,209Direct
Trade date
Jun 4, 2026Option exercise
Filed
Jun 5, 2026, 7:48 PM ET1-day reporting delay
Accession
0001493152-26-027573Code M · Transaction 100089
How reported position traded is calculated

Calculated only for code-P purchases and code-S sales.

Row-level estimate for this security and ownership context, not the insider’s complete portfolio. Joint ownership, other transactions in the filing, amendments and footnotes can affect interpretation.

Other trades in this filing

Trade dateActivitySharesPriceValueDetails
Jun 5, 2026Tax withholding35,901$0.39−$13,821.89Trade 100090
Jun 4, 2026Option exercise119,880$0.00$0Trade 100091
3 transaction rows in this filing. Joint filers share the same rows.

MVIS price since this filing

Daily closing prices, with the filing date and available return windows. Return methodology
MVIS · Daily closing priceDaily price data is pending. The chart appears when valid daily closes are available.
Filing dateReturn windows appear as prices become available.
Pre-filing1mo ago +69%1w ago +62%1d ago +7.7%
Returns since7d −7.7%30d −5.1%90d180d1y

Footnotes in full

F1: Vested restricted stock units, or RSUs, were distributed to the Reporting Person, without payment, in shares of common stock on a unit-for-share basis. F2: Represents a withholding tax-related nondiscretionary sell-to-cover transaction completed by the Issuer in accordance with the terms of the award agreement. F3: The price reported in column 4 is a weighted average price. These shares were sold by the Issuer in multiple transactions at prices ranging from $0.3850 to $0.3852, inclusive. F4: At vesting, converts into shares of common stock on a unit-for-share basis. F5: On June 4, 2024, the Issuer's Compensation Committee approved a grant of RSUs, which are scheduled to vest as to 33% on each annual anniversary of the grant date until fully vested on June 4, 2027, subject to the Reporting Person's continued employment with the Issuer on each vesting date.